Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for ??????????? ???????? ??? ?????? ?? ???-???????? ????? ?????????? ?? ????????/?????????? ????-??????? ????? ??????? ????????: ? ?????????? ?????? ??? ????-????????

AML - 750

??????????? ???????? ??? ?????? ?? ???-???????? ????? ?????????? ?? ????????/?????????? ????-??????? ????? ??????? ????????: ? ?????????? ?????? ??? ????-????????

Mishal Tariq

Poster Presenter: Mishal Tariq

Thumbnail for Co-Mutational Patterns and Transcriptomic Heterogeneity Within NPM1-Mutated Acute Myeloid Leukemia: An Integrative Analysis Using the ASH HematOmics Program

AML - 758

Co-Mutational Patterns and Transcriptomic Heterogeneity Within NPM1-Mutated Acute Myeloid Leukemia: An Integrative Analysis Using the ASH HematOmics Program

Wajeeha Aiman

Poster Presenter: Wajeeha Aiman

Previous 1...40 41 42 43 44 45 46...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Efficacy of Revumenib in Acute Myeloid Leukemia Harboring NPM1-Mutated Co-Mutations: Post Hoc Analysis of AUGMENT-101

AML - 773

Efficacy of Revumenib in Acute Myeloid Leukemia Harboring NPM1-Mutated Co-Mutations: Post Hoc Analysis of AUGMENT-101

Ghayas Issa

Poster Presenter: Ghayas Issa

Thumbnail for Treatment Patterns and Outcomes of Ivosidenib in Patients With mIDH1 AML Previously Treated With Venetoclax-Based Regimens: A Real-World Analysis

AML - 776

Treatment Patterns and Outcomes of Ivosidenib in Patients With mIDH1 AML Previously Treated With Venetoclax-Based Regimens: A Real-World Analysis

Vanessa Kennedy

Poster Presenter: Vanessa Kennedy

Thumbnail for Analysis of Cytogenetics, Molecular Profiling, and Survival in 190 Children with Newly Diagnosed Acute Myeloid Leukemia: A Single-Center Experience

AML - 778

Analysis of Cytogenetics, Molecular Profiling, and Survival in 190 Children with Newly Diagnosed Acute Myeloid Leukemia: A Single-Center Experience

Diyora Xusanova

Poster Presenter: Diyora Xusanova

Thumbnail for Immune Cell Type Abundance Predicts Survival of Pediatric Acute Myeloid Leukemia Patients at Diagnosis

AML - 781

Immune Cell Type Abundance Predicts Survival of Pediatric Acute Myeloid Leukemia Patients at Diagnosis

Jaclyn Shaw

Poster Presenter: Jaclyn Shaw

Thumbnail for Upfront Allogeneic Stem Cell Transplantation With Individualized Venetoclax-Based Conditioning in MECOM-Rearranged Acute Myeloid Leukemia: A Single-Center Retrospective Study

AML - 783

Upfront Allogeneic Stem Cell Transplantation With Individualized Venetoclax-Based Conditioning in MECOM-Rearranged Acute Myeloid Leukemia: A Single-Center Retrospective Study

Milda Mikalonyt?

Poster Presenter: Milda Mikalonyt?

Thumbnail for Real-World Treatment Patterns and Outcomes With Olutasidenib After Venetoclax in IDH1-Mutated Acute Myeloid Leukemia Using Electronic Health Record Data

AML - 784

Real-World Treatment Patterns and Outcomes With Olutasidenib After Venetoclax in IDH1-Mutated Acute Myeloid Leukemia Using Electronic Health Record Data

Yasmin Abaza

Poster Presenter: Yasmin Abaza

Thumbnail for Is MRD Negativity a Valid Surrogate for Overall Survival in RandomizedTrials of Acute Myeloid Leukemia?

AML - 791

Is MRD Negativity a Valid Surrogate for Overall Survival in RandomizedTrials of Acute Myeloid Leukemia?

Vivian Reis Ferrarez

Poster Presenter: Vivian Reis Ferrarez

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors